高雅光學(00907.HK)擬成立不同附屬 分別開展酒類、眼鏡及黃金珠寶相關業務
格隆匯6月4日丨高雅光學(00907.HK)公吿,集團全資附屬公司東創新投發展有限公司("東創新投")擬(i)主要從事(其中包括)酒類及食品調味料相關業務的發展及銷售;及(ii)於中國成立不同附屬公司,分別開展酒類、眼鏡及黃金珠寶相關業務。
監於公司的業務擴展計劃,董事會謹此通知股東及潛在投資者,公司可能考慮各種資金籌集途徑,包括但不限於進行供股,以籌集額外資金,以為上述擬進行的業務活動提供資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.